ChemoCentryx, Inc. Deferred Tax Assets, Net of Valuation Allowance
ChemoCentryx, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $9.28 million as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2022-03-01
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.28M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $7.55M.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $358.00K.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $8.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2021-12-31 | $9.28M 10-K · filed 2022-03-01 |
| 2020-12-31 | $7.55M 10-K · filed 2022-03-01 |
| 2019-12-31 | $358.00K 10-K · filed 2021-03-01 |
| 2018-12-31 | $8.00K 10-K · filed 2020-03-10 |